专题：Neurological and metabolic disorders

This cluster of papers focuses on the association between hyperglycemia, basal ganglia lesions, and various movement disorders such as chorea, hemichorea-hemiballismus, and seizures. It explores the clinical manifestations, neuroimaging findings, differential diagnosis, and management of hyperglycemic chorea and related conditions in patients with diabetes or uremia.
最新文献
Revisiting Nomenclature in Movement Disorders: The Boundaries Between Pragmatism, Academicism, and Practical Applicability

article Full Text OpenAlex

Neuropsychiatric Symptoms in Patients With Pathologically Confirmed Comorbid Alzheimer Disease and Frontotemporal Lobar Degeneration

article Full Text OpenAlex

Opioid-associated amnestic syndrome (OAS) following cerebellar hippocampal and basal nuclei transient edema with restricted diffusion (CHANTER) syndrome triggered by opioid overdose: A case report

article Full Text OpenAlex

Mixed primary progressive aphasia and alcohol use disorder: a case of detailed clinical phenotyping outperforming molecular imaging

article Full Text OpenAlex

Association of Cortical Free Water With Brain Tau Tangle Load in the Alzheimer Disease Continuum

article Full Text OpenAlex

Quetiapine induced global aphasia: A case report

article Full Text OpenAlex

Abstract TP264: Comparative Performance of 7T and Conventional MRI for CAA Markers

article Full Text OpenAlex

Analysis of prognostic factors in acute encephalopathy with biphasic seizures and late reduced diffusion: a retrospective study on MRI findings and the treatments

article Full Text OpenAlex

Serum biomarkers of postanoxic encephalopathy in relation to ghrelin treatment. A secondary analysis of the GRECO trial

article Full Text OpenAlex

Metformin-Associated Encephalopathy as a Rare but Serious Adverse Effect: A Case Report

article Full Text OpenAlex

近5年高被引文献
Mitochondria ROS and mitophagy in acute kidney injury

article Full Text OpenAlex 668 FWCI52.9138

Intracranial atherosclerotic stenosis: risk factors, diagnosis, and treatment

article Full Text OpenAlex 268 FWCI37.2415

Accelerated Brain Volume Loss Caused by Anti–β-Amyloid Drugs

review Full Text OpenAlex 194 FWCI39.8846

Equivalence of plasma p‐tau217 with cerebrospinal fluid in the diagnosis of Alzheimer's disease

article Full Text OpenAlex 150 FWCI33.9302

18F-FDG PET Imaging in Neurodegenerative Dementing Disorders: Insights into Subtype Classification, Emerging Disease Categories, and Mixed Dementia with Copathologies

article Full Text OpenAlex 149 FWCI20.2879

Amyloid-Related Imaging Abnormalities with Emerging Alzheimer Disease Therapeutics: Detection and Reporting Recommendations for Clinical Practice

article Full Text OpenAlex 121 FWCI13.8296

Functional brain networks in the evaluation of patients with neurodegenerative disorders

review Full Text OpenAlex 98 FWCI10.5974

Journal of Pediatric Neurology

paratext Full Text OpenAlex 94 FWCI0

Pathophysiology of reversible cerebral vasoconstriction syndrome

review Full Text OpenAlex 88 FWCI12.5337

Classification of Dystonia

review Full Text OpenAlex 84 FWCI6.3032